Trial characteristics
	Further details
Single centre/Multi‐centre
Country/Countries
How was participant eligibility defined?
How many people were randomly assigned?
Number of participants in each intervention group/Control group	/
Number of participants who received intended treatment
Number of participants who were analysed
Anaesthesia drugs
Dose of neostigmine
Anticholinergic agents/Dose
Dose of placebo
Trial design (e.g. parallel/Cross‐over*)
Neuromuscular monitoring	Quantitative means/Qualitative means/Not
Other